INVESTORS' PRESENTATION OverviewNews Events & Presentations Financials Governance Stock Resources Progressive Care Engages ClearThink to Lead Expanded Investor Relations Program NOVEMBER 30, 2021 Focus on Increasing Awareness and Enhancing Stockholder Value Miami, FL – November 30, 2021 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that it has retained ClearThink Capital (“ClearThink”), a strategic advisory firm, to develop and deploy a comprehensive investor outreach and communications program. “We believe we are now ready to enter the next growth phase of our business, as we recently filed our S-1 Registration Statement in order to become fully reporting and compliant with the U.S. Securities and Exchange Commission, ”stated, Alan Jay Weisberg, Chairman and Chief Executive Officer of Progressive Care. Weisberg, continued, “Our mission to improve every step of the patient journey by adding value to prescribers, caregivers and patients in a seamless manner has led us to growth in revenue, improved margins and an improvement in the company’s overall cash flow. We hired The Benchmark Company to lead our capital markets initiative to uplist to Nasdaq. As we look to this positive momentum, our Board and management believe it is an appropriate time to retain a proactive strategic investor relations firm to help us reach new potential investors and effectively communicate our investment thesis. We are confident that ClearThink will help us convey our strategy, business objectives and corporate milestones to a wider audience of sophisticated investors and improve our visibility and awareness.” Brian Loper, Senior VP and Account Manager of ClearThink, commented, “With its unique model for pharmacy operation and data management, SaaS-based revenue streams, digital health technologies, expanded penetration of its PharmCo-branded operations, improved financials and clear path in becoming SEC reporting, we believe Progressive Care’s investment proposition is compelling, and the ClearThink team is eager to elevate the company's IR efforts. These efforts will include implementing a comprehensive targeting strategy to communicate a clearer and more concise message to an expanded audience of relevant investors that we expect, over time, should help unlock and drive stockholder value.” ClearThink is a consulting firm known for its ability to connect underfollowed and undervalued smaller reporting companies with sophisticated institutional investors, buy-side and sell-side analysts, retail brokerage firms and accredited individual investors. Leveraging decades of cumulative experience, ClearThink develops strategies to help clients effectively communicate with the investment community and works to increase their exposure through targeted outreach and transparent positioning. ClearThink helps public companies deliver the right message to the right audience. Over time, ClearThink helps its clients navigate up the Wall Street value chain and to help them secure a reasonable valuation by broadening their audience, expanding institutional ownership and ensuring clear, consistent communication with the public. ‍ About Progressive Care: Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of Third-Party Administration (TPA), data management, COVID-19 related diagnostics and vaccinations, 340B contracted pharmacy services, prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management. For more information about Progressive Care, please visit the company’s website. Connect and stay in touch with us on social media: ‍ Progressive Care Inc. https://www.progressivecareus.com/ https://twitter.com/ProgressCareUS PharmCoRx https://www.pharmcorx.com/ https://twitter.com/PharmCoRx ClearMetrX https://www.clearmetrx.com/ https://www.facebook.com/clearmetrx/ ‍ Forward-Looking Statements: Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. ‍ Public Relations Contact: Carlos Rangel carlosr@pharmcorx.com Investor Relations Contact: ‍ Brian Loper ClearThink bloper@clearthink.capital Investors' Presentation Full overview of RXMD's performance DOWNLOAD NOW CONTACT US: INFO@PROGRESSIVECAREUS.COM COMPANY OVERVIEW NEWS STOCK INVESTOR'S FAQ CONTACT US PRIVACY POLICY ACCREDITED AS SEEN ON COPYRIGHT 2020 © PROGRESSIVE CARE INC. FORWARD-LOOKING STATEMENTS – CERTAINSTATEMENTS INCLUDED IN THIS PRESENTATION THAT ARE NOT HISTORICAL OR CURRENT FACTS INCLUDING, BUT NOT LIMITED TO, THOSE RELATED TO OUR FINANCIAL AND BUSINESS EXPECTATIONS AND OUTLOOK, THE IMPACT OF THE EVOLVING AND UNCERTAIN HEALTHCARE ENVIRONMENT, STRATEGY AND GROWTHDRIVERS, UTILIZATION AND PATIENT VOLUME TRENDS, REVENUE VISIBILITY, ANTICIPATEDMEMBERRENEWALS OF GPO PARTICIPATION AGREEMENTS, CROSS AND UPSELL OPPORTUNITIES, ACQUISITIONACTIVITIES AND PIPELINE, REVENUE AVAILABLE UNDER CONTRACT, PURCHASESUNDEROUR SHARE REPURCHASE PROGRAM AND THE FINANCIAL IMPACT OF SHARE REPURCHASES, TAX REFORM AND COST SAVINGS EFFORTS, POTENTIAL DIVIDEND PAYMENTS, AND2020 FINANCIALGUIDANCE AND RELATED ASSUMPTIONS ARE “FORWARD-LOOKING STATEMENTS” WITHIN THE MEANING OF THE FEDERALSECURITIES LAWS. FORWARD-LOOKING STATEMENTS MAY INVOLVE KNOWNAND UNKNOWN RISKS, UNCERTAINTIES AND OTHER FACTORS THAT MAY CAUSE THE ACTUAL RESULTS TO BE MATERIALLY DIFFERENT FROM HISTORICAL RESULTS OR FROM ANY FUTURE RESULTS OR PROJECTIONS EXPRESSED OR IMPLIED BY SUCH FORWARD-LOOKING STATEMENTS. ACCORDINGLY, READERSSHOULD NOT PLACE UNDUE RELIANCE ON ANY FORWARD LOOKING STATEMENTS. READERS ARE URGED TO CONSIDER STATEMENTS IN THE CONDITIONAL OR FUTURE TENSES OR THAT INCLUDE TERMS SUCH AS “BELIEVES,” “BELIEF,” “EXPECTS,” “ESTIMATES,” “INTENDS,” “ANTICIPATES” OR “PLANS”TO BEUNCERTAINAND FORWARD-LOOKING.FORWARD-LOOKING STATEMENTS MAY INCLUDE COMMENTS REGARDING THE COMPANY ’S BELIEFS AND EXPECTATIONS AS TO FUTURE EVENTS AND TRENDS AFFECTING ITS BUSINESS AND ARE NECESSARILY SUBJECT TO UNCERTAINTIES, MANY OF WHICH ARE OUTSIDE COMPANY’S CONTROL. YOU SHOULD CAREFULLY READ COMPANY’S PERIODIC AND CURRENT FILINGS WITH THE OTC MARKETS FOR MORE INFORMATION ON POTENTIAL RISKS AND OTHER FACTORS THAT COULD AFFECT THE COMPANY AND ITS FINANCIAL CONDITION OR RESULTS OF OPERATIONS. FORWARD-LOOKING STATEMENTS SPEAKONLY AS OFTHE DATE THEY ARE MADE. THE COMPANY UNDERTAKES NO OBLIGATION TO PUBLICLY UPDATE OR REVISE ANY FORWARD-LOOKING STATEMENTS. ‍NON-GAAP FINANCIALMEASURES–THIS PRESENTATIONINCLUDES CERTAIN “NON-GAAP FINANCIAL MEASURES” AS DEFINED IN REGULATION G UNDER THE SECURITIES EXCHANGE ACT OF 1934. SCHEDULES ARE ATTACHED THAT RECONCILE THE NON-GAAP FINANCIAL MEASURES INCLUDED IN THIS PRESENTATION TO THE MOST DIRECTLY COMPARABLE FINANCIAL MEASURES CALCULATEDAND PRESENTEDIN ACCORDANCEWITH GENERALLY ACCEPTED ACCOUNTING PRINCIPLES IN THE UNITED STATES. YOU SHOULD CAREFULLY READ PROGRESSIVE CARE’S PERIODIC AND CURRENTFILINGS ON THE OTCQB WEBSITE FOR DEFINITIONS AND FURTHER EXPLANATION AND DISCLOSURE REGARDING OUR USE OF NON-GAAP FINANCIAL MEASURES AND SUCH FILINGS SHOULD BE READ IN CONJUNCTION WITH THIS PRESENTATION.